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RESEARCH ARTICLE
Analysis of RNA-Seq datasets reveals enrichment of tissue-specific splice
variants for nuclear envelope proteins
Charlotte Capitanchik *a, Charles R. Dixon a, Selene K. Swansonb, Laurence Florens b, Alastair R. W. Kerr a,
and Eric C. Schirmer a
aThe Wellcome Centre for Cell Biology and Institute of Cell Biology, University of Edinburgh, Edinburgh, UK; bStowers Institute for Medical
Research, Kansas City, MO, USA
ABSTRACT
Laminopathies yield tissue-specific pathologies, yet arise from mutation of ubiquitously-expressed
genes. A little investigated hypothesis to explain this is that the mutated proteins or their partners
have tissue-specific splice variants. To test this, we analyzed RNA-Seq datasets, finding novel
isoforms or isoform tissue-specificity for: Lap2, linked to cardiomyopathy; Nesprin 2, linked to
Emery-Dreifuss muscular dystrophy and Lmo7, that regulates the Emery-Dreifuss muscular dys-
trophy linked emerin gene. Interestingly, the muscle-specific Lmo7 exon is rich in serine phos-
phorylation motifs, suggesting regulatory function. Muscle-specific splice variants in non-nuclear
envelope proteins linked to other muscular dystrophies were also found. Nucleoporins tissue-
specific variants were found for Nup54, Nup133, Nup153 and Nup358/RanBP2. RT-PCR confirmed
novel Lmo7 and RanBP2 variants and specific knockdown of the Lmo7 variantreduced myogenic
index. Nuclear envelope proteins were enriched for tissue-specific splice variants compared to the
rest of the genome, suggesting that splice variants contribute to its tissue-specific functions.
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Introduction
Nuclear envelope (NE) links to inherited disease
yielded the conundrum of how mutations in widely
expressed proteins can yield many distinct patholo-
gies, each focused in different tissues [1]. The NE is a
double membrane system comprised of inner (INM)
and outer (ONM) nuclear membranes and asso-
ciated proteins that must integrate all communica-
tion between the nucleus and the rest of the cell and
tissue. Most trafficking of proteins, nucleotides, and
small molecules through the NE is directed by the
nuclear pore complexes (NPCs), built from >30
nucleoporin (nup) proteins together with a host of
transport factors [2]. Less used mechanisms also
exist for membrane fusion [3,4] and autophagy
[5,6]: factors required for both mechanisms were
identified in NE proteomics studies [7–10]. Signals
can also be passed through mechanotransduction
[11–13], which relies on connections between cyto-
plasmic filament systems and the intermediate fila-
ment lamin nucleoskeleton underlying the inner
surface of the INM. The primary proteins making
the connections are SUN and nesprin proteins,
respectively INM and ONM NE transmembrane
proteins (NETs) that form the linker of nucleoskele-
ton and cytoskeleton (LINC) complex [14,15]. Other
INM NETs directly connect to chromatin and
directly participate in genome regulation [16,17].
Mutations leading to human disease have been
found in all these NE components. Mutations in
many different nucleoporins lead to particular can-
cers each affecting a particular tissue [18]. Some
nucleoporin mutations also cause tissue-specific
inherited diseases such as Triple A syndrome from
Aladin and infantile bilateral striatal necrosis from
Nup62 [19,20]. Over 400 different mutations in the
LMNA gene, encoding nucleoskeletal component
lamin A, cause a wide spectrum of debilitating
tissue-specific monogenic disorders despite that
LMNA is near-ubiquitously expressed. These range
from several muscular dystrophies and cardiomyo-
pathy to dermopathy, neuropathies, and several
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lipodystrophies [21,22]. Similarly, despite their ubi-
quitous expression, both the SUN and nesprin
LINC complex components are mutated in
Emery-Dreifuss muscular dystrophy [23,24] and
nesprin mutations also cause autosomal recessive
cerebellar ataxia, a brain-specific neuropathy [25].
The INM NETs emerin and LAP1 are linked to
muscular dystrophies while LBR and MAN1 are
linked to bone disorders [26–29]. At the same
time, LBR also is linked to the blood disorder
Pelger-Huet anomaly [30]. One hypothesis for
how tissue-specificity in pathology is achieved
with the aforementioned mutations in widely
expressed proteins is that the mutations disrupt
binding to tissue-specific interaction partners.
Previously identification of tissue-specific NETs
focused on the level of expression, with hundreds
of NETs restricted in expression to specific tissues
being discovered through proteomics of NEs
extracted from muscle, liver, and blood [7–10].
Additionally, some NPC components have differ-
ential expression such as Nup358 in skeletal myo-
genesis [31], Nup133 in mouse embryonic
development [32], and Nup210 in muscle and neu-
ronal differentiation [33,34].
Tissue-specific alternative pre-mRNA splicing
presents another mechanism to generate tissue-spe-
cific NE proteins. LMNA is spliced to encode princi-
pally lamin A and lamin C, the relative levels of
which vary between cell types though both are near
ubiquitously expressed [35]. There are also two rare
but widely expressed splice variants: lamin AΔ10 and
progerin [36]. Progerin is principally expressed in
patients with Hutchison-Gilford Progeria Syndrome
and is reported to be expressed in normal aging [37].
Though some NETs have many known splice var-
iants such as Lap2 with at least six (α, β, Υ, δ, ε, ζ)
[38–40], these have not been investigated in detail
for their tissue-specificity of expression. There are
two exceptions to this. First, many tissue-specific NE
protein splice variants have been reported for testis
including lamins B3 (spliced from the LMNB1 gene)
and C2 (spliced from the LMNA gene), and SUN
variants [41–44]. The other exception is the nesprin
family: several tissue-specific splice variants have
been reported for both the larger nesprins 1 and 2.
Known isoforms of nesprin-1 range in size from 53
kDa to >1,000 kDa, with the shortest isoforms being
expressed exclusively in human cardiac and skeletal
muscle tissues [45,46]. More recently, siRNA deple-
tion of distinct SUN1 splice forms has been shown to
either increase or decrease breast cancer cell migra-
tion depending on the isoform depleted [47].
Furthermore, mutations linked to muscular dystro-
phies are located near to a variable region of the
protein that is partially excluded in the SUN1_888
isoform [47]. Critically, defects in the splicing of NE
genes can cause disease [48–50].
Identifying tissue-specific splice variants of
these proteins is important because different var-
iants can have distinct partners and cellular loca-
lizations. Functional studies of NE proteins
typically rely on exogenous expression of the
more widely expressed isoforms, so that important
functional differences in tissue-specific isoforms
would be missed. Though several large easily
searchable databases exist for tissue-specific gene
and protein expression [51–54], the best resource
for predicted splice isoforms is the Vertebrate
Alternative Splicing and Transcription Database
(VastDB). VastDB contains information about
splicing events collected from 1,478 RNA-Seq
datasets covering human, mouse, and chicken
across different tissues, cell lines, and developmen-
tal contexts [51]. However, identification of alter-
nately spliced transcripts by RNA-Seq does not
indicate whether they are actually translated.
Efforts were previously engaged to find support
for novel splice variants identified by RNA-Seq in
mass spectrometry data, but have been met with
limited success. We postulated that our tissue-spe-
cific datasets of the NE organelle would have suffi-
cient depth to increase the likelihood of identifying
peptides covering splice junctions and set out to
test this. Though mostly finding first protein evi-
dence for previously annotated splice variants, the
analysis identified several novel tissue-specific
splice variants. Furthermore, testing specific splice
variants in mouse C2C12 myogenesis confirmed
their presence and their knockdown yielded aber-
rations in myogenesis.
Results
NE genes are enriched in alternative splicing
We previously determined the NE proteome from
rat liver and muscle and human blood and found
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that most NE proteins are tissue-restricted [7–10].
While much of the tissue-specificity observed cor-
related at the level of expression [8], several pro-
teins were also observed that were expressed
widely, but only targeted to the NE in certain
tissues [55]. One possible explanation for such
proteins is that the tissue with unique NE localiza-
tion of the protein also expressed a unique tissue-
specific variant carrying a NE targeting sequence.
A large number of spectra generated in mass spec-
trometry studies are not matched to peptides. This
is generally attributed to non-unique sequences or
unknown, or not searched for, post-translational
modifications, but it could also be explained by
tissue-specific splice variants that are not anno-
tated in the databases so that the sequences are
not searched for in the mass spectrometry analysis.
The likelihood that there are many as yet not
annotated splice isoforms is underscored by the
increasing number of annotated transcripts with
each major new annotation release (Supplemental
Figure S1A). Accordingly, we sought to search for
evidence of tissue-specific splicing of NE proteins.
To find such splice variants we engaged a workflow
(Supplemental Figure S1B) to first identify all tran-
scripts containing different splice junctions in RNA-
Seq data. As most of our mass spectrometry data was
in rat, it was important tomatch this to RNA-Seq data
from rat, which was missing from VastDB. Therefore,
we analyzed RNA-Seq data from five rat tissues (heart,
skeletal muscle, liver, brain, and testes) produced by
two separate research groups, hereby referred to as
GSE4 and GSE5 [54,56]. GSE4 has higher read cover-
age over junctions, but only one suitable sample per
tissue, while GSE5 has lower coverage but many repli-
cates. Novel junctions identified in both datasets were
considered to be high confidence. Differentially
spliced transcripts were determined and quantified
using Modeling Alternative Junction Inclusion
Quantification (MAJIQ) software. Splice junctions
rather than whole isoforms were quantified due to
the known limitations in reconstructing whole tran-
scripts from short read data [57,58]. The software
builds splice graphs from RNA-Seq reads spanning
spliced junctions, incorporates un-annotated junc-
tions, and uses information from replicate samples to
build a Bayesian posterior distribution, outputting the
expected percentage spliced in values (E(PSI)) corre-
sponding to the percentage of transcripts that are
expected to contain the given splice junction or in
the case of a comparison, change in PSI (E(dPSI)). In
accordance with previous literature, we considered an
alternative splicing event between tissues when E
(dPSI) ≥ 0.2.
Datasets from multiple labs were examined such
that the identification of novel isoforms could be as
robust as possible. As we were particularly interested
in myogenesis splice variants due to the links of the
NE to multiple muscular dystrophies, we also ana-
lyzed three mouse C2C12 myogenesis RNA-Seq
datasets from three different labs withmultiple repli-
cates. These were considered similar enough based
on clustering in principle component analysis (PCA)
that they could be combined and analyzed together
using MAJIQ (Supplementary Figure S2).
Considering alternative splicing to be associated
with E(dPSI) ≥ 0.2 and using a subset of NE pro-
teomics datasets that was enriched in NEs over an
endoplasmic reticulum (ER)-enriched fraction,
1947/3487 (56%) mouse NE mRNAs were alterna-
tively spliced across the developmental transitions
and tissue types studied. 1461/2963 (49%) rat NE
mRNAs were alternatively spliced in the union set
of the two five-tissue rat sets analyzed, with 327 of
these genes being identified in both experiments.
To our surprise, genes encoding NE proteins were
enriched in alternative splicing between tissues in
both rat datasets and in the C2C12 myogenesis
model system (Figure 1(a)). NE genes represent
17% of all expressed genes on average, but are
over-represented in genes differentially spliced
between tissues, comprising 27.5% on average
between datasets (Kolmogorov-Smirnov Test,
p-value < 0.0001).
Enriched alternative splicing might relate to the
number of exons, and therefore available splice sites,
in a gene. The number of annotated exons in NE
genes versus non-NE genes was examined to see if
there was a clear distinction. This analysis was per-
formed for NE genes versus non-NE genes expressed
during myogenesis and for the five tissue rat sets. It
was important to perform the comparison against
expressed genes and not all annotated genes because
the NE genes by definition of being identified in
proteomics screens are expressed. Information
from each gene was downloaded from Ensembl
BioMart, and the transcript with the highest number
of exons for each expressed gene was considered. On
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average, NE protein encoding genes had more exons
than the average for non-NE protein encoding genes
in the genome (Figure 1(b)).
Previous studies demonstrated that alternatively
spliced exons are enriched in intrinsically disor-
dered regions of proteins [59,60]. Although pre-
diction algorithms for intrinsic disorder are still in
their infancy for high confidence and high-
throughput analysis, it has been suggested for
yeast NETs that intrinsic disorder is a common
property [61]. Searching for intrinsic disorder
using IUPred and filtering for ≥ 20 amino acid
stretches of disorder against the longest rat
sequence available in Ensembl revealed the pre-
sence of intrinsically disordered regions in 44%
(1283/2913) rat NE proteins compared to 34%
for the rest of the proteins encoded by the genome.
While this was highly significant by counts
(Fisher’s Exact Test, p-value < 0.0001), using the
alternative hypothesis that the true odds ratio is
not equal to 1 with a 95% confidence interval gives
only a slightly higher odds ratio of 1.302.
Searching NE-enriched proteomics datasets for
splice junction peptides
Tissue-specific junction sequence databases were
generated for rat muscle and liver tissues. In each
case the union of all splice junctions detected by
STAR aligner for each replicate from GSE4 and
GSE5 was taken. Junctions were filtered to remove
junctions supported by less than 6 reads (a threshold
adopted from [62,63]) and junctions predicting an
intron length of less than 60 nucleotides (a standard
cut-off as there are very few smaller annotated junc-
tions) (Supplementary Figure S3). Junction coordi-
nates were extended by 66 nucleotides in both
directions, and then translated in three frames
according to the directionality of the gene [62,63].
This produced peptide sequences of ~44 amino acids
in length. Sequences were removed if the translation
produced a stop codon before the junction based on
standard practice [62,63]. Novel exons and intron
retentions predicted by MAJIQ were similarly trans-
lated in three frames and added to the database, but
Figure 1. Enrichment of alternatively spliced variants in NE genes. (a) The proportion of expressed genes whose protein products are
found at the NE was compared to the proportion of spliced genes encoding a NE protein. Each dot represents a comparison between
two tissues or developmental stages, for example muscle vs. liver or myoblast vs. myotube. To determine expressed genes the union
of all genes considered to be expressed in both conditions was taken. Whether a gene was expressed was determined in two
different ways (described in the methods), but here just the variance stabilizing transformation (VST) method is shown as it gave a
more conservative estimate. To determine spliced genes, all genes that contained a differential splicing event with E(dPSI) ≥ 0.2
between the two conditions were taken, as calculated with MAJIQ. (b) The maximum exon number per gene was compared for NE
genes vs. non-NE genes and it was found that NE genes have more exons on average than other expressed genes in myogenesis and
five rat tissues. Note that only genes expressed in either mouse myogenesis or in the five rat tissues studied were considered, as
otherwise the plots were skewed towards genes with very low exon numbers.
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were removed if the translated sequence was less
than 7 amino acids long. All novel and annotated
junctions were combined with novel exons, intron
retentions, and Ensembl rat protein database
sequences to produce a final protein sequence data-
base. Finally, coordinates of junction peptides were
checked against the original fasta sequence to be sure
that the peptide crossed the junction with a start ≤22
amino acids away and an end ≥22 amino acids away.
In total, by re-analyzing our previously
described NE-enriched proteomic datasets
obtained from liver and muscle, we found 183
unique junction-spanning rat peptides that sup-
port 84 un-annotated rat junctions. Of these, 74
junctions occurred in regions of the rat transcrip-
tome that are not annotated to genes; however, the
corresponding sequences were annotated in
human and mouse transcriptomes and more than
half (44 of 74) corresponded to the titin gene. The
remaining 8 previously not annotated rat junctions
occurred in rat annotated genes for Atl3, Camk2a,
Mta1, Rbm7, Ryr1, Safb2, Top2b, and LAP2; how-
ever, all of these junctions had been previously
annotated in human or mouse.
While the identification of novel splice variants
detected by this method was lower than we had
anticipated, looking at the tissue dataset specificity
of several splice junction peptides suggested that
LAP2α, LAP2δ and LAP2γ are preferentially
expressed in rat liver and not muscle (Figure 2).
In contrast, for other regions of LAP2 39 peptides
were identified in liver and 23 peptides in muscle,
suggesting that overall levels and coverage of the
total isoform pool was similar. The possible tissue-
specific expression of LAP2 isoforms in rat liver
could potentially have relevance to human disease
because there are several laminopathy links to liver.
For example, a laminopathy case caused by a het-
erozygous R133L Lamin A mutation presented as a
generalized lipodystrophy with hepatic steatosis
[64] and several other laminopathies, particularly
lipodystrophies, present with hepatic distress. Most
significantly, LAP2 itself has recently been linked to
nonalchoholic fatty liver disease [65].
Tissue-specific NE gene junctions are discovered
in multiple independent RNA-Seq datasets
Although we found evidence for the translation of
many splice variants, the peptide coverage for
most proteins was much lower than for proteins
such as LAP2, thus significantly lowering the
probability of recovering the less abundant splice
junction peptides. Thus, while the presence of
splice junction peptides supports the presence of
the translated product, the absence of splice junc-
tion peptides is not evidence of the absence of the
protein product. Accordingly, we searched for
Figure 2. Peptide support for Lap2, showing a similar number of peptides over the whole protein in liver and muscle, but evidence
for specific isoforms comes from liver samples only.
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tissue-specificity of possible novel splice variants
using just the RNA-Seq data.
To examine tissue-specific splice junctions we
used the two rat body map datasets. In order to
establish which splice junctions were tissue-spe-
cific a scoring system was designed in which E
(dPSI) values for each tissue comparison were
stored in separate tables for each tissue. Then,
the E(dPSI) values were thresholded at a value
of 0.2 such that a 1 indicates inclusion of the
splice junction in the tissue described in the spe-
cific table and a 0 describes exclusion or no
change. The scores were tallied and transferred
to a separate table for comparison. A splice junc-
tion was defined to be tissue-specific when it had
a higher final score for one tissue compared to all
others tested. For example, a highly muscle-spe-
cific junction would have a muscle table score of
4 (the maximum number of comparisons possible
with 5 tissues), and scores of 0 for liver, heart,
testes and brain. Taking this very stringent defi-
nition of tissue-specificity, we found that, consis-
tent with the literature, testes and brain had the
most specific splice junctions and this was the
case whether testing just NE genes or non-NE
genes (Figure 3(a)).
To test if any of these NE un-annotated splice
junctions were tissue-specific, we assigned the
highest scoring tissue to each splice junction,
and where two or more scores were tied we
called the splice junction not specific (NA). In
this way, 349 of the novel NE splice junctions
are assigned as tissue-specific, with 105 not hav-
ing a clear tissue specificity (Figure 3(b)). It
might be that genes with these tissue-specific
splice junctions have different roles to those
where tissue-specificity is not as clearly defined.
To check this we searched for gene ontology
(GO) terms associated with each group using
LAGO from the Princeton GO server [66]
(http://go.princeton.edu/cgi-bin/LAGO). To our
surprise the enrichment of GO terms was very
different for the two groups. Genes containing
novel splice junctions with a clearly defined tis-
sue-specificity were enriched in GO terms con-
cerning RNA processing, whereas genes that we
could not classify in this way were enriched in
GO terms related to structure and development
(Figure 3(b)).
Tissue-specific NE gene isoforms in genes
relevant to nuclear envelope disease
In our analysis of the RNA-Seq data we identified
novel variants for several genes relevant to nuclear
envelope disease.
Lmo7 – Emerin is an INMprotein, that binds both
lamin A and the BAF complex and is frequently
mutated in Emery-Dreifuss muscular dystrophy.
Lmo7 is a regulator of emerin [67]. We identified a
novel exon in Lmo7 (mm10, chr14:101886131–
101886331, Rn6, chr15:86407592–86407792) that
we were unable to find described in any database.
The exon is 201 bp long, and when spliced together
with neighbouring exons is expected to be translated
in-frame. There is evidence for inclusion of the exon
in heart (E(PSI) = 0.695) and skeletal muscle tissue
(E(PSI) = 0.769) in rat and differentiated myotubes
in mouse (PSI = 0.44) across all datasets studied
(Figure 4(a,b); note that the myogenesis junction
was not detected by stringent MAJIQ analysis and
so was calculated manually as described in the meth-
ods). Interestingly, a reasonable match to the exon
appears in the gene sequence for all mammals and
some avian species, but is notably absent in turkey,
amphibians and fish (Figure 4(c)).
The expected amino acid sequence is serine-
rich (Figure 4(d)) and so the sequence was
searched for possible phosphorylation sites with
PhosphoMotif Finder [68]. This software searches
for the presence of sequences that have been
identified in the literature, but does not perform
statistical tests. In the rat sequence 8 possible
phosphorylated serine binding motifs and 81 pos-
sible serine kinase/phosphatase motifs were pre-
dicted (Figure 4(d)). Many of these are in
conserved regions of the sequence, for example
the RRNS motif at the beginning of the sequence
is a reported binding motif for 14-3-3 proteins,
which are involved in cell signalling and tran-
scriptional regulation [69]. The likelihood of
high phosphorylation together with Lmo7 being
only partly at the NE and thus of low abundance
for recovered peptides and spectra readily explain
its not being recovered in the mass spectrometry
data.
Syne2 – The SYNE genes encoding nesprin pro-
teins have been directly linked to Emery-Dreifuss
muscular dystrophy [24]. We found transcriptome
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Figure 3. RNA support for novel tissue-specific splice variants through scoring of splice junctions according to their unique
appearance in particular tissues. (a) The appearance of individual splice junctions in the GSE4 (light blue) and GSE5 (dark blue)
tissue datasets was quantified for brain, heart, liver, muscle and testes. A scoring system (see text) for tissue-specificity was
applied and the number of genes with tissue-specific splice junctions for each tissue is plotted. Brain and testes have the most
specific isoform expression both when just considering genes encoding NE proteins and when considering non-NE protein
genes. In total, 6,709 previously un-annotated differentially spliced junctions were identified for rat between the GSE4 and
GSE5 datasets, 24% (1,622) of which were in NE genes. Many of these, however, were not found in both datasets. The
intersection of the two datasets yielded 1,634 novel splice junctions, of which 28% (454) were in NE genes. (b) Most novel
junctions in NE genes are tissue-specific and there seems to be a functional difference between those that can be defined as
tissue-specific and those that are non-specified. The pie chart shows the tissue-specificity of the 454 ‘intersect’ un-annotated
splice junctions in NE genes that were identified to be differentially spliced in both rat body map datasets. The graphs show
the number of genes significantly enriched in GO term categories (p ≤ 0.01) as determined by LAGO analysis for tissue-specific
genes (bottom) and non-tissue-specific genes (top).
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evidence for a testes-specific nesprin 2 isoform that is
not annotated in human, mouse or rat Ensembl (E
(PSI) = 0.4). It seems to represent a novel transcrip-
tion start site, as it is only connected to the down-
stream exons (Rnor6 junction coordinate –
chr6:98995844–98997669). Note that junction cover-
age in the region is especially poor: the junction is
quantified by MAJIQ in the GSE5 sample due to the
replicates, although there is still evidence for the
junction in GSE4 (Figure 5(a,b)).
Lap2 (Tmpo) – Lap2 is linked to dilated cardio-
myopathy and hepatic steatosis [65,70]. In a poten-
tially very exciting new aspect of Lap2 regulation, we
discovered tissue-specific antisense transcripts in the
Lap2 (Tmpo) gene that are confirmed by their
appearance in both rat tissue datasets. This was
incorrectly called as alternative splicing of Lap2 by
MAJIQ analysis of the unstranded GSE5 dataset,
thus highlighting the importance of using stranded
RNA-Seq and checking potential splice variants in a
genome browser. One internal antisense transcript is
specific to muscle and another directed away from
the transcription start site is specific to testes
(Figure 6(a,b), respectively). The testes transcript is
an annotated lncRNA in human and was identified
from human prostate samples [71], but it is not
annotated in mouse or rat and to our knowledge
the tissue-specificity of this lncRNA has not been
Figure 4. An unannotated exon in the regulator of emerin Lmo7 that is specific to heart and skeletal muscle. (a) Genome browser
tracks show RNA-Seq read coverage over Lmo7, with the novel exon highlighted by a red arrowhead. GSE4 and GSE5 refer to two rat
body map datasets produced by independent labs. E(PSI) values represent expected percent spliced in (PSI) values calculated by
MAJIQ. (b) Again showing genome browser tracks, but for mouse C2C12 myogenesis data where each replicate is a representative
sample from data from an independent lab. (c) PhyloP conservation track shows that the genomic region containing the novel exon
is highly conserved between vertebrates. (d) Alignment of the mouse and rat exon amino acid sequences shows the high level of
conservation, with non-conserved amino acid residues highlighted in red. Blue and orange lines indicate regions of the sequence
where serine phosphorylation motifs and serine binding motifs respectively were identified by PhosphoMotif Finder.
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previously reported. Our discovery suggests that not
only is this lncRNA conserved to rat, it is also highly
tissue-specific and it seems likely it could be involved
in regulating the expression of LAP2 isoforms in
prostate and testis. The muscle-specific internal anti-
sense transcript is located between exons 2 and 3. It
is seemingly not annotated in any species and its
function is unclear, however its proximity to the
muscle specific LAP2α domain encoding exon 4
suggests that it could be involved in regulating this
soluble isoform during myogenesis.
Other potentially disease-relevant novel isoforms
in muscle proteins
FHL3 is closely related to FHL1 that is directly
linked to Emery-Dreifuss muscular dystrophy
[72]. FHL3 regulates the expression of muscle-
Figure 5. A novel testes-specific exon in Syne2. (a) Sashimi plot for GSE4 samples shows that even though the junction is not
considered quantifiable by MAJIQ in this sample there are still reads spanning the junction. (b) Big wig files show GSE5 tracks as well.
Figure 6. There is novel tissue-specific transcription in antisense to the Lap2 gene. Sashimi plots are shown for stranded GSE4 RNA-
Seq samples, showing forward and reverse strand read coverage for each tissue studied. Tissue-specific transcription in antisense to
the Lap2 gene is highlighted in pink boxes. (a) There is a muscle-specific transcription in antisense to Lap2 that is not annotated. (b)
There is also transcription in antisense to the Lap2 start site, which is specific to testes. This transcript is not annotated in rat,
however there is a similar transcript annotated in human.
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specific genes in myogenesis, including MyHC
[73]. In studying mouse myogenesis, we identified
a novel exon in FHL3, that is present in both
myoblast and myotube transcripts in RNA-Seq
datasets from three independent groups (Figure 7
(a)). Whilst the exon is included in both myoblast
and myotube FHL3 transcripts, the inclusion iso-
form shifts from being the dominant isoform in
myoblast (E(PSI) = 0.611), to being a minor iso-
form in myotube (E(PSI) = 0.443), suggesting that
the change might be biologically relevant. We were
unable to find any corresponding exon in rat tissue
RNA-Seq, and there is no Ensembl annotation in
rat, human or mouse for this exon. Given that the
CDS begins in annotated exon 2, we expect this
exon to be an extension of the 5′UTR and so could
potentially be involved in regulating translation of
the transcript.
Ywhae is a 14-3-3 protein that has been iden-
tified as a biomarker in mice with a limb girdle
muscular dystrophy type E phenotype [74] and
was identified in the NE proteomics datasets.
We found evidence in the rat data for the pos-
sible muscle-specific expression of an exon in
Ywhae that was previously only annotated in
humans. This exon is highly specific to skeletal
muscle tissue in rat (E(PSI) = 0.7) and is speci-
fically expressed in myotube during mouse
Figure 7. Additional novel splice variants with potential links to disease. (a) Novel alternative start in FHL3 detected in mouse C2C12
myogenesis. Sashimi plot shows raw coverage over junctions, with light blue denoting myoblasts and dark blue indicating
myotubes. E(PSI) values are taken from MAJIQ analysis grouping together all samples from three independent labs. Mb: myoblast,
Mt: myotube. (b) Ywhae has a muscle-specific exon in rat. Sashimi plot shows raw junction coverage over Ywhae for 5 rat tissues
with one representative plot for each tissue, but the exon is observed in both rat tissue datasets. The blue transcript represents
Ensembl 90 annotation. (c) The muscle-specific exon in rat is conserved in mouse and is specifically included in myotube. Mb:
myoblast, Mt: myotube. Each track represents one sample from an independent lab for each condition.
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C2C12 myogenesis, although it is estimated to
be present in only 7% of Ywhae transcripts
(Figure 7(b,c). However, it also appears to be
included to a much lesser extent in rat heart (E
(PSI) = 0.143) and brain tissue (E(PSI) = 0.025).
This is interesting because human diseases invol-
ving Ywhae tend to be heart or brain specific.
For example, Ywhae has a role in neuronal
migration, which is thought to be disrupted in
Miller–Dieker syndrome [75]. While our data
does not resolve full isoforms of Ywhae, there
is only one annotated splice isoform in human
containing this exon and it is a shorter isoform
(732 bp, coding for 115 amino acids, where the
longest annotated transcript is 2211 bp, coding
for 255 amino acids), but there is no literature
on the tissue-specific functions of this isoform.
Our results argue that this splice variant is
conserved to mouse and rat and is highly tis-
sue-specific in its expression.
Novel tissue-specific nucleoporin isoforms
We also identified novel tissue-specific isoforms in
several nucleoporin proteins that are distributed
throughout the nuclear pore complex (Figure 8
(a)). These included a testes-specific exon skipping
event in Nup153 (Figure 8(b); E(PSI) = 0.225) and
a novel muscle-specific 78 bp exon in RanBP2
(Figure 8(c); E(PSI) = 0.556) that are not anno-
tated in human, mouse or rat. A Nup54 brain-
specific exon is annotated in human, but not
mouse (Figure 8(d); PSI = 0.96), however to our
knowledge it has not previously been reported that
the exon is brain-specific. Furthermore, we found
Figure 8. Multiple novel tissue-specific variants of nucleoporins were uncovered. (a) A schematic of the nuclear pore complex with
novel tissue-specific splice variants annotated with their tissue-specificity. (b) For Nup153 a sashimi plot is shown to demonstrate the
testes-specific exon skipping, the numbers over junctions are raw read coverage. (C-D) For RanBP2, Nup54 and Nup133 BigWig
tracks are shown. For the rat data the top track for each tissue is GSE4, while the two below represent two replicates from GSE5. In
the case of RanBP2 mouse C2C12 myogenesis data is also shown, where each track for the two conditions (Mb: Myoblast, Mt:
myotube) is a representative sample from a dataset produced by independent labs.
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evidence for a novel testes-specific isoform in
Nup133 (E(PSI) = 0.61).
The RanBP2 exon was also found to be spe-
cific to myotube in mouse C2C12 myogenesis
(Figure 8(c), lower panel; E(PSI) = 0.410). The
predicted amino acid sequence is located
between a Ran binding domain and an E3 ligase
domain and contains repeating proline and leu-
cine residues with no premature termination
codon. VastDB was checked for record of this
Figure 9. Functional validation of RanBP2 and Lmo7 novel splice variants in mouse C2C12 myogenesis. (a) RT-PCR for the novel
myotube-specific exons reveals that they are spliced into mRNA produced in C2C12 mouse cells differentiated into myotubes (*
marks novel splice form). Adjacent diagrams indicate the primer design and expected amplicon sizes. Note that for Lmo7 a third
splice isoform is expected (marked with a question mark), however we don’t observe this in our gels (MB: myoblast, MT: myotube).
(b) siRNAs against either the novel exon junction (NEJ), or canonical exon junction (CJ), or against a separate exon (e11), result in
reduced mRNA expression of the specific RanBP2/Lmo7 splice variants. Novel splice variants are marked by an arrowhead. siCTL
refers to treatment with a non-target control siRNA. Transfection control refers to treatment with the transfection reagents alone,
but no siRNA. Tables next to each gel show the proportion of the novel and canonical isoforms in each quantifiable lane, as
measured using the in-built gel analyzer tool in Fiji. (c) Quantification of myogenic index (percentage of nuclei in myotubes) as
determined by myosin heavy chain 1 staining (red) in 4 day differentiated myotubes. The numbers above the points represent mean
values from three biological replicates, the mean is also indicated with black crosses. * represents a statistically significant difference
(p < 0.0001) between knockdown and non-target siRNA control conditions as measured using a Fisher’s exact test on the
aggregated replicates. (d) Example fields of view used for determination of myogenic index in (c). Scale bars = 15 μm.
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exon and while no record was found for mouse,
there is a 78 bp exon described for the human
RanBP2 gene, which fits the inclusion profile
observed in the current study. Taken together,
there is very strong evidence for the conserved
alternative splicing of this un-annotated cassette
exon in vertebrate muscle.
Functional validation of novel splice variants
To validate some of the new splice variants in
muscle development, mouse C2C12 myoblast cells
were differentiated into myotubes in culture, RNA
extracted, and analyzed by RT-PCR for the pre-
sence of the muscle-specific splice variants
(Figure 9(a)). This clearly confirmed the expression
of the novel Lmo7 and RanBP2 splice variants.
To assess potential functions of the tissue-specific
splice variants they were specifically targeted by
siRNAs in the C2C12 cells without affecting the
canonical splice isoforms (Figure 9(b)). The myo-
blasts containing the siRNAs were induced to dif-
ferentiate into myotubes so that the induced splice
forms would be immediately targeted for degrada-
tion once they began to be expressed. By internally
normalizing the signal from the novel isoform to
the canonical isoform (novel/canonical+novel) we
estimated that there was an 8% reduction in the
novel RanBP2 isoform and a 36% reduction in the
amount of the novel Lmo7 isoform in 4 day differ-
entiated myotubes after treating with the specific
siRNAs. Additionally, at day 4 the differentiated
cultures were quantified for myogenic index by
counting the number of nuclei in fused myotubes
over the total number of nuclei in the population.
We observed a reduction in successful fusion under
the specific knockdown of the Lmo7 muscle-speci-
fic splice variant, in three independent biological
replicates, with the difference ranging from 6–17%
compared to a non-target siRNA control
(Figure 9(c)). We aggregated the replicates and
found the difference between specific and non-tar-
get siRNA treatment to be statistically significant
(Fisher’s Exact Test, p-value < 0.0001), although
due to the variability in the control conditions no
firm conclusions can be drawn. Although there was
no significant reduction in the myogenic index for
the muscle-specific RanBP2 splice variant knock-
down, images appeared to indicate some
morphological differences such as in myotube
thickness (Figure 9(d)) that may be of interest to
further investigate in the future. Whether this or
other subtle effects on differentiation are confirmed
and can be linked to functional deficits such as
mechanical function remains to be determined.
Discussion
The original hypothesis for this study was that the
use of tissue-specific organelle proteomics datasets
would increase the likelihood of confirming transla-
tion of predicted tissue-specific splice variants both
because the mass spectrometry data would be better
matched and have greater depth from starting with
an enriched fraction. While 183 unique junction-
spanning peptides were identified, none of these
turned out to be novel, due to poor rat genome
annotations and this number reflects only a small
fraction of the splice variants predicted from the
RNA-Seq data. Whether this reflects a need for
even greater depth in the mass spectrometry analysis
or that most splice variants predicted by RNA-Seq
data are not translated cannot be answered with the
existing data, but several interesting observations
nonetheless came from this work. First, much more
splicing is conserved to rat and mouse in NE pro-
teins than previously appreciated, suggesting impor-
tant functional consequences for these splicing
events. Moreover, alternate splicing is actually
enriched in NE proteins as well as the presence of
intrinsically disordered domains. This is consistent
with ideas of NE proteins being involved in many
different tissue-specific interactions and that alter-
native splicing is a means to modulate this.
Intriguingly, many of the tissue-specific proteins
are associated with RNA processing GO-terms, sug-
gesting an unexpected role where tissue-specificity in
the NE might propagate a wider cellular tissue-spe-
cificity through RNA processing. Most importantly,
both the RNA-Seq and proteome analysis strongly
support the prevalence of tissue-specific splice var-
iants at the NE.
One such muscle-specific splice variant adds a
novel exon in the regulator of emerin, Lmo7.
Lmo7 acts as a transcription factor, activating the
expression of emerin; however, Lmo7 also binds to
emerin, reducing the pool of the protein available
to act as a transcription factor and creating a
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negative feedback loop to downregulate emerin
expression [67]. The predicted amino acid
sequence of the novel exon is serine-rich and con-
tains many possible phosphorylation sites, along
with binding motifs for protein domains that bind
phosphorylated serine residues. It seems likely that
addition of this exon could confer a unique reg-
ulatory function to Lmo7 specifically in muscle
tissues. Given its role in regulating emerin, this
splice variant may be highly relevant for the
study of Emery-Dreifuss muscular dystrophy
(EDMD). In fact, the mild reduction in myogenic
index is actually more strongly supportive of this
idea than a block in myogenesis would be, because
muscles develop and appear relatively normal
before disease presentation typically when children
become more active.
The finding of predicted novel alternative splicing
events or novel antisense transcription in both other
laminopathy-linked genes encoding nesprin 2 and
Lap2 and other muscular dystrophy-linked genes
such as FHL3 underscore the need for this type of
analysis. When studying the function of genes rele-
vant to muscular dystrophies, commonly genetic
constructs are produced using commercially avail-
able cDNAs. Novel exons, such as those noted
above, likely confer significant tissue-specific bind-
ing partners and/or regulation to these proteins.
This could include loss of major partners under
current investigation with commercial cDNAs or
gaining of completely unknown partners that
would only bind or be identified in pulldowns
using the specific splice form. Regulation could
include changes in protein post-translational mod-
ifications, cellular targeting, specific cleavage or
overall protein stability. Therefore, it is important
for researchers to use cDNAs that properly match
tissue-specific sequences that could potentially be
relevant to these diseases.
The novel tissue-specific exons for several nucleo-
porins uncovered raises a new and mostly unex-
pected mode of tissue-specific regulation at the NE
– in control of protein trafficking. While some NPC
components were known to have some tissue-speci-
fic variation in expression [31–34], the existence of
tissue-specific splice variants was largely unexplored.
This is not completely surprising in that transport
receptors, particularly importin alpha, have long
been known to have a variety of isoforms due to
alternate splicing. The different isoforms are also
consistent with a study indicating cell-type specific
stoichiometries for NPCs [76]. This alternate spli-
cing, as for the laminopathies, could contribute to
tissue-specific disorders linked to these NPC pro-
teins. For example, RanBP2 is implicated in many
neurological conditions including Familial acute
necrotizing encephalopathy (https://www.targetvali
dation.org/target/ENSG00000153201/associations?
view=t:table) caused by missense mutations,
Parkinson’s disease due to its direct binding of the
Parkin protein [77], and potentially Amyotrophic
Lateral Sclerosis for which similar symptoms are
achieved by RanBP2 knockout in mice [78].
RanBP2 is also associated with a wide range of can-
cers [18]. These data together argue that it is critical
to identify all tissue-specific nuclear envelope splice
variants and focus studies on using these specific
isoforms in matched tissue systems. This study is a
starting point and there is much more work needed
to decipher the specific functions of these novel
splice forms.
Materials and methods
Datasets used
RNA-Seq from three mouse C2C12 myogenesis
datasets and two rat body map datasets were
used, summarized in Table 1.
RNA-Seq mapping and quality control
Reads were aligned to mouse (mm10) or rat (Rn6)
genomes as appropriate using STAR (v2.4.2a) in
two-pass mode [82]. Genome indexes were gener-
ated with Ensembl 89 annotations and produced
independently for each mapping to avoid propaga-
tion of spurious alignments, although this could be
considered conservative [83]. In the final stages junc-
tions were compared against the latest Ensembl
release (90) to ensure that they were truly novel.
The median percentage of uniquely mapped reads
across all samples used in the study was 85.51%
(Max: 92.48; Min: 69.88). FastQC (v0.11.2) was
used to check the quality of reads (https://www.
bioinformatics.babraham.ac.uk/projects/fastqc/)
and where necessary adaptors were trimmed using
cutadapt (v1.9.1) [84] or Trim Galore! (v0.3.3)
(https://omictools.com/trim-galore-tool) where
quality trimming was also applied. rRNA regions
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were removed from bam files with BEDtools
(v2.26.0) intersect -v, using a list of rRNA gene
coordinates obtained from Ensembl BioMart
[85,86]; additionally the 7SL gene was blacklisted as
this region was over-represented in several samples.
For viewing many datasets in the Integrative
Genomics Viewer (IGV) bigWig files were generated
using deepTools (v2.5.1) bamCoveragewith the flags–
minMappingQuality 255 (to exclude multimapping
reads) and – normalizeUsingRPKM so that tracks
would be represented on a similar scale [87,88].
Splicing analysis
Differential usage of exon-exon junctions was quanti-
fied using MAJIQ (v1.0.3)[52]. Default settings were
used with the critical criteria being – min_denovo 2,
– minreads 3 and – min_intronic_cov 1.5 for the
builder step, and – minreads 10 and – minpos 3 for
the deltapsi step. Where a value is presented as E(PSI)
this has been calculated using MAJIQ. Some novel
events were identified outside of the MAJIQ analysis
by screening genes of interest and in these cases PSI of
a novel exon is calculated as: novel exon inclusion
junctions (NEIJ)/(canonical exclusion junction (CEJ)
* 2) + novel exon inclusion junctions (NEIJ) and
reported in the text as PSI, rather than E(PSI). For
myogenesis this value is presented as an average of
three representative samples from the three datasets
studied and in the case of the rat five tissue analysis
this presents the value calculated from GSE4 samples.
For the rat body map data, datasets A and B were
analyzed independently. The builder step was run
on all tissue samples together and pairwise compar-
isons were made using the deltapsi module.
Following this, E(dPSI) values for all splicing events
in all tissue comparisons were combined into a
single table. This table was processed using an R
script to split splicing events into their component
exon-exon junctions and assign a score ranking the
inclusion of individual junctions in skeletal muscle,
heart, liver, brain and testes tissues.
To score the inclusion of a junction in a specific
tissue, tissue-specific tables were generated contain-
ing each possible comparison to that tissue and
thresholded at E(dPSI) ≥ 0.2, where changes in PSI
above this threshold were given a score of 1 and
below this a score of 0. Scores were added for each
tissue-specific table to give an overall tissue score,
this gives an indication of the number of
comparisons for which the junction was more
included in the given tissue (Supplementary table 1).
For the mouse C2C12 myogenesis data all three
datasets were analyzed together in MAJIQ, using the
automatic weights feature to downweight outlier
samples [89]. Splicing events with E(dPSI) ≥ 0.2
were considered to be differentially spliced. We
checked our results against previously published stu-
dies to validate our approach (Supplementary
Figure S4).
Enrichment analysis
To establish lists of expressed genes for each con-
text, featureCounts was used to assign reads to
gene-level counts and then DeSeq2 Variance
Stabilizing Transformation (VST) was applied
[90,91]. A calibration curve was produced where
increasing cut off values were used to select
expressed genes. Using this method there is a
clear cut-off value where the group of genes selected
decreases from all genes to a set of genes. The cut
off was a normalized expression value of 3.1 for
myogenesis and 3.8 for the rat body map data.
We supplemented this by also performing the
analysis with genes that had an abundance of ≥1
transcripts per million (TPM)(GSE4:
Supplementary Table 3A, GSE5: Supplementary
Table 3B, C2C12 myogenesis: Supplementary
Table 3C). Considering a gene’s count to be Ni
and its length to be Li TPM was calculated as:
TPMi ¼ 106 Ni=Lið Þ=Σj Nj=Ljð Þ:
Intrinsic disorder analysis
The longest Ensembl annotated protein per gene
was analyzed using IUPred (http://iupred.enzim.
hu/). The number of amino acids with a score
over 0.5 was recorded and number of proteins
that had at least 20 such amino acids was counted.
Mass spectrometry analysis
The latest protein database for Rattus norvegicus
(Rnor 6.0) was downloaded from Ensembl (ftp://
ftp.ensembl.org/pub/release-90/fasta/rattus_norvegi
cus/pep/Rattus_norvegicus.Rnor_6.0.pep.all.fa) and
exactly redundant sequences were removed keeping
only one representative entry, leading to 27,229 non-
redundant protein sequences. After adding usual
contaminants (including keratins and proteases), all
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proteins entries were shuffled to estimate false dis-
covery rates (FDRs), resulting in 54,836 amino acid
sequences. Tissue-specific fasta databases for anno-
tated and un-annotated splice junctions (192,897
and 177,043 amino acid sequences in the liver and
muscle databases, respectively) were concatenated,
144,611 exactly redundant sequences were removed,
and eachNR protein entry was randomized (keeping
the same amino acid composition and length). This
annotated and novel junctions database was
appended to the non-redundant Ensembl rat protein
database described above to generate one database
containing 252,554 rat proteins and junctions
sequences, 193 contaminants, and 252,747 shuffled
sequences. ProLuCID (v 1.3.3) [92] was used to
search MS/MS datasets obtained from four NaOH-
extracted and three Salt-and-Detergent extracted
liver NE samples and four NaOH-extracted and
two Salt-and-Detergent extracted liver NE protein
samples. All protein samples had been digested
with trypsin and analyzed by MudPIT as described
previously [8,10]. To account for alkylation by chlor-
oacetamide, 57 Da were added statically to cysteine
residues, while 16 Da were added as a differential
modification to methionines. Peptide/spectrum
matches were sorted and selected using DTASelect/
CONTRAST[93]. All 13 datasets were compared
using CONTRAST: combining all runs, proteins
had to be detected by at least 2 peptides and/or 13
spectral counts, leading to average low FDRs of
0.15% and 0.03% at the protein and spectral levels,
respectively. To report all splice junction peptides
passing selection criteria, proteins that were subsets
of others were NOT removed using the parsimony
option inDTASelect. Proteins that were identified by
the same set of peptides (including at least one pep-
tide unique to such protein group to distinguish
between isoforms) were grouped together, and one
accession number was arbitrarily considered as
representative of each protein group. To estimate
relative protein levels and to account for peptides
shared between proteins, normalized spectral abun-
dance factors (dNSAFs) were calculated for each
detected protein, as previously described [94]. A
full table of results is presented in Supplementary
Table 2.
The original raw instrument files for these mus-
cle and liver datasets may be obtained from the
Massive repository: ftp://MSV000081166@massive.
ucsd.edu and ftp://MSV000081167@massive.ucsd.
edu, using MSV numbers as login and EH93JR as
password.
Cell culture and transfection
C2C12 myoblasts (MBs) were cultured under
ATCC-recommended conditions, except fetal
bovine serum was used at a final concentration of
20%. MBs were induced to differentiate at 24 h post-
confluency by removal of culture medium and the
addition of DMEM with 2% horse serum.
Differentiation media was replaced every 24 h up
to 96 h post-induction. Because we have often
observed loss ofmyotubes due to strong contractions
that break ECM interactions, 1 μM tetrodotoxin was
added at 72 h post-induction to inhibit contraction.
Cells were transfected with siRNAs to specific splice
variants as myoblasts using Lipofectamine 2000
(ThermoFisher) 24 h prior to starting differentiation
induction. siRNAs used were as follows: siCTL Sense
– AAUUCUCCGAACGUGUCACGUdTdT,
Antisense – ACGUGACACGUUCGGAGAAU
UdTdT, siRanBP2:NEJ Sense -ACCUGAGAGC
AAAGCACAAdTdT, Antisense – UUGUGC
UUUGCUCUCAGGUdTdT, siRanBP2:CJ Sense –
AGGCACAAGAGAAGAGCAAdTdT, Antisense -
UUGCUCUUCUCUUGUGCCUdTdT, RanBP2:
e11 Sense – CCAGUCACUUACAAUUAAAdTdT
(Note, this siRNA was used in a previous study
[31]), Antisense – UUUAAUUGUAAGUGACU
GGdTdT, Lmo7:NEJ Sense – CAGGGAUUCAG
AAGGAAUUdTdT, Antisense -AAUUCCUUCU
GAAUCCCUGdTdT (Sigma).
Differentiated myotubes were stained with
myosin heavy chain 1 (Myh1) mouse monoclonal
antibody clone My-32 (M1570 Sigma) together
with 4,6-diamidino-2 phenylindole, dihy-
drochloride (DAPI). Images were acquired on a
Nikon TE-200 microscope using a 1.45 NA 100x
objective, Sedat quad filter set, PIFOC Z-axis
focus drive (Physik Instrubments) and a
CoolSnapHQ High Speed Monochrome CCD
camera (Photometrics) run by Metamorph
image acquisition software. Myogenic index was
calculated as the percentage of total nuclei as
assessed by DAPI staining that occurred within
Myh1-stained myotubes in the population at
4 days post induction of differentiation. 5 fields
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across 3 biological replicates were counted to
determine the myogenic index.
Reverse transcription PCR (RT-PCR)
cDNAs were generated using the Thermoscript II
RNAse H – Reverse Transcriptase as per manufac-
turer’s instructions. Briefly, following annealing to a
polyA primer at 65°C, 2 μg of total RNA was incu-
bated with 1X Thermoscript RNAse H- reaction
buffer, 10 U RNAsin, 10mM DTT, 1μM dNTPs
mix and 200 U Thermoscript II RNAse H –
Reverse Transcriptase. Tubes were vortexed, centri-
fuged briefly, and incubated at 42°C in a thermo-
cycler with the heated lid at 80°C for 3 h. After heat
inactivation of the reverse transcriptase by a 15 min
incubation at 70°C, RNA was removed by incubat-
ing samples with 1 μL of 7 mg/ml RNAse A for
45 min at 37°C. cDNA was diluted with 90 μl of
water and the reactions stored at −20°C.
For RT-PCR, 20 μl reactions containing 100ng
of diluted cDNA and 1 μM forward and reverse
primers were used. Primers for RT-PCR were
designed using the Primer3 PCR web tool and
were: RanBP2 forward primer 5′-CTGAAACA
ACACCAAAAGCAGT-3′, RanBP2 reverse primer
5′-GGGGTGGGAGTGAGTTCATA-3′, Lmo7 for-
ward primer 5′ GTGCCAGCACCTTTGAGG-3′
and Lmo7 reverse primer 5′- CCATTCTCACCA
TAGATC-3′.
Bands from the RT-PCR were quantified using
the in-built gel analyzer tool in Fiji [95]. The
proportion of novel exon junction (NEJ) inclusion
to canonical junction (CJ) inclusion was calculated
by taking raw intensity NEJ/(raw intensity CJ +
raw intensity NEJ) or vice versa for quantifying
the CJ.
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